VERTEX PHARMACEUTIC (NASDAQ:VRTX)
38.54
0.38 (0.98%)
| VERTEX PHARMACEUTIC (NASDAQ:VRTX) Delayed : |
| Previous Close |
$38.92 |
|
52 Week High |
$41.75 |
|
| Open |
$38.70 |
|
52 Week Low |
$19.87 |
| Day High |
$39.15 |
|
P/E |
N/A |
| Day Low |
$38.54 |
|
EPS |
$-3.84 |
| Volume |
1,590,772 |
|
|
|
| More VRTX Info:
Chart
SEC Filings
Profile
Historical
Options
|
View All ReportsStreetInsider.com Reports on VRTX
-
Nov 17, 2009 07:23 AM
Merriman Curhan Ford Downgrades Vertex Pharmaceuticals (VRTX) to Neutral; Valuation Call
-
Nov 10, 2009 03:24 PM
Vertex Pharma (VRTX) January puts spreaders active on low volatility
-
Nov 4, 2009 08:32 AM
Morgan Stanley Upgrades Vertex (VRTX) to Overweight
-
Nov 2, 2009 02:05 PM
Analysts Mixed as Results from Trial of Vertex's Telaprevir Send the Stock Higher (VRTX)
-
Nov 2, 2009 01:48 PM
Unusual 11 Mid-Day Movers 11/02: HGSI, EAC, IUSA, VRTX Higher; CIT, YRCW, GTXI, CPF Lower
View All Reports
StreetInsider Reports on VRTX by Category
-
Nov 2, 2009 04:57 PM
Innovative Drug Companies Headline the Gainers
-
Nov 2, 2009 03:58 PM
Monday Options Update: XLF, ETFC, CF, HGSI, EEM, BEBE, SMH and VRTX
-
Nov 2, 2009 03:38 PM
Monday Options Recap
-
Oct 27, 2009 07:19 AM
Wall Street Breakfast: Must-Know News
-
Oct 9, 2009 12:05 PM
Analyst upgrades, downgrades and initiations: VIA, RIMM, ARO, JPM, BMY
View All Blogs
Comments on recent VRTX articles
Comments on VRTX
No comments are currently available.
on Aug 15, 2008
at 11:06 AM Cure of hepatitis Is there a way to place an low amount of an antibacterial formula w/ isopropyl alcohol which would bring fungus/ mold/ bacteria out of the system.
Article: Vertex Pharma (VRTX) Higher On Analyst Upgrade